PEN
PEN
NYSE · Health Care

Penumbra Inc

$321.11
-1.34 (-0.42%)
Financial Highlights (FY 2026)
Revenue
1.41B
Net Income
178.36M
Gross Margin
67.1%
Profit Margin
12.7%
Rev Growth
+18.3%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.1% 67.1% 62.3% 62.3%
Operating Margin 13.5% 12.1% 10.5% 11.3%
Profit Margin 12.7% 12.0% 6.5% 7.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.41B 1.19B 10.27B 10.50B
Gross Profit 945.98M 799.44M 6.40B 6.54B
Operating Income 189.93M 144.46M 1.08B 1.18B
Net Income 178.36M 135.65M 671.18M 794.53M
Gross Margin 67.1% 67.1% 62.3% 62.3%
Operating Margin 13.5% 12.1% 10.5% 11.3%
Profit Margin 12.7% 12.0% 6.5% 7.6%
Rev Growth +18.3% +18.3% +21.2% -0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 100.27M 100.27M 6.99B 7.31B
Total Equity 6.19B 6.19B 5.78B 6.06B
D/E Ratio 0.02 0.02 1.21 1.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 190.41M 152.87M 1.52B 1.81B
Free Cash Flow — — 854.42M 874.28M